Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous lymphocyte therapy
- Development stage
- Unknown
- Lead developer
- Xiangtan Central Hospital
- Modality
- Cell Therapies
- Administration
- Subcutaneous
01
Overview
Autologous lymphocyte therapy is an experimental cell-based immunotherapy being investigated for the treatment of chronic urticaria. The procedure involves the isolation of lymphocytes from the patient's own peripheral blood, which are then processed and re-administered via subcutaneous injection. The therapy aims to modulate the immune response, potentially by inducing immune tolerance or altering the activity of effector cells like basophils and eosinophils, which are central to the pathogenesis of chronic urticaria. It is currently being evaluated in early-stage clinical trials in China, specifically at Xiangtan Central Hospital, to assess its efficacy in reducing symptom scores and its impact on peripheral blood cell populations.
- Other names
- autologous lymphocyte immunotherapyautologous lymphocytes
02
Targets
Neoantigen-specific T-cell receptor
Beyond the preview
Go deeper on autologous lymphocyte therapy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous lymphocyte therapy.